| Open Joint Stock Company "Borisov Plant of Medical Preparations" | |
|---|---|
| Type of | State enterprise |
| Location | Republic Belarus: Borisov |
| Key Figures | Deresh Vitaly Vasilyevich (General Director) |
| Industry | Production of medicines |
| Products | Magnecard |
| turnover | US$131 million |
| Number of employees | 3000 |
| Website | www.borimed.com |
Open Joint Stock Company "Borisov Plant of Medical Preparations" is a leading manufacturer and exporter of broad-spectrum medicines in the Republic of Belarus. Borisov Plant of Medicinal Products has 4 main production facilities, as well as auxiliary services (printing and cardboard shop, mechanical repair shop, energy department, instrumentation and automation department, repair and construction department, transport department with a fleet of vehicles, etc.) located in Borisov, Minsk region.
The plant is an open joint stock company and is subordinate to the Republican Unitary Enterprise “Managing Company of the Belfapmprom Holding”.
Medicinal products produced by OJSC "BZMP" are supplied to 24 countries of the world: the CIS countries, Moldova, Georgia, the USA, the countries of Central and Southeast Asia, the countries of the Middle East. The volume of industrial production in actual prices for 2017 amounted to 252.7 million BYN (equivalent to 131 million US dollars).
On the territory of the plant there is a Production Unitary Enterprise "Frebor" with a 100% authorized share of the capital of OJSC "BZMP", specializing in the production of single-use medical products. The product line consists of more than 150 items and is divided into two categories: consumables for hemodialysis therapy and general medical products.
STORY
JSC "BZMP" was founded in 1965. The history of the enterprise began with the organization of a small pharmaceutical factory with 257 employees. The company produced tinctures, ointments, oils and tablets.
PRODUCTION
The enterprise covers an area of more than 10 hectares, its production facilities include 5 main workshops, as well as auxiliary services. The number of employees is about 3000 people. The plant produces more than 280 types of medicines of 12 pharmacotherapeutic groups - generics:
- injection solutions in ampoules;
- powders for preparation of solutions for injections in vials;
- solid dosage forms (tablets);
- liquid phytochemical, alcohol and oil medicines;
- soft dosage forms;
- drugs in hard gelatin capsules.
The company specializes in the production of medicines for the treatment of the following diseases:
- cardiovascular system (Magnekard®, Aspicard®, Ramipril, Bisoprolol, Trimetazidine with modified release, Emoxicard®, Detraven®, etc.);
- diabetes mellitus (Metformin, Gliclazide, Gliclazide modified release);
- neurological diseases (Spasmaton Neo®, BoriVit®, Soothing drops, Revalon®, Choline alfoscerate);
- gastrointestinal tract (Lanzazol®, Ranitidine, Bisacodyl)
- infectious diseases (cephalosporin antibiotics: Cefazolin, Cefuroxime, Ceftriaxone, Cefotaxime, etc.)
- and others.
The organization's annual output is more than 5 billion tablets, 500 million ampoules, 185 million capsules, 50 million bottles of antibiotics in the form of sterile powders, 13 million tubes of ointments and gels, 10 million bottles of tinctures and alcohol solutions.
QUALITY SYSTEM
THE MAIN PRODUCTION SITES OF JSC "BZMP" ARE CERTIFIED FOR COMPLIANCE WITH:
- production to the requirements of the TCP RB 030-2013 (02040) "Good Manufacturing Practice (GMP)" (10 certificates);
- conclusion on the compliance of the manufacturer (foreign manufacturer) of medicinal products for medical use with the requirements of the Rules of Good Manufacturing Practice No. GMP-00075/16/BY, issued by the Ministry of Industry and Trade of the Russian Federation on 12.12.2016;
- production of medicines to the GMP requirements of the PIC/S member countries (Ukraine), (Certificate No. 088/2015/SAUMP/GMP issued on 12/21/2015);
- production of tablets of valerian extract, folic acid to the requirements of the Regulation of the European Parliament and of the Council, issued by the Latvian Certification Center (Certificate No. 0.852/2004 issued on 29.04.2004).
JSC "BZMP" HAS THE FOLLOWING CERTIFIED MANAGEMENT SYSTEMS:
- the quality management system for the development and production of medicines and dietary supplements meets the requirements of STB ISO 9001-2009;
- environmental management system for the production and wholesale of medicines (ecological certificate) STB ISO 14001-2005;
- occupational safety management system for the development, production of medicines and dietary supplements STB ISO 18001-2009.
The area of the plant is 11 hectares. The number of employees is more than 2700 people. The plant produces approximately 200 types of medicines of 12 pharmacotherapeutic groups - generics. And constantly replenishes the list of its products - every year at least 10 of the most popular drugs. More than 5 billion tablets, 500 million ampoules, 90 million capsules, 20 million bottles of antibiotics in sterile powders, 13 million tubes - ointments, gels produced by the plant annually improve the health of people in many countries of the world.
The volume of industrial production in actual prices for 2014 amounted to 1,100.0 billion rubles. (equiv. - 111.1 million US dollars).
Medicinal products manufactured by JSC "BZMP" are supplied on a regular basis not only to the neighboring Russian Federation and Ukraine, but also to Azerbaijan, Armenia, Afghanistan, Vietnam, Georgia, Egypt, Iraq, Yemen, Kazakhstan, North Korea, Kyrgyzstan, Latvia, Lebanon, Lithuania , Macedonia, Moldova, Uzbekistan, Somalia, USA, Tajikistan, Turkmenistan, Estonia. The plant plans to significantly expand the geography of sales in the very near future: to master the markets of South America, Africa, and Asian countries. This is facilitated by the active implementation of the GMP quality system at the enterprise. For impressive export volumes, the Open Joint Stock Company "Borisov Plant of Medical Preparations" is traditionally noted as the best exporter of the year: 2008, 2010, 2012, 2013, 2014. Every year the plant increases the volume of export products: on average for the period 2011-2014. - by 8%.
The volume of exports of products for 2014 amounted to 58 million US dollars.
The open joint-stock company "Borisov Plant of Medical Preparations" relies on continuous development and modernization: 300 production technologies already mastered by the enterprise are supplemented with new ones, the equipment fleet is regularly updated, production is consistently certified for compliance with GMP standards.
It should be noted that the priority market for the Open Joint Stock Company "Borisov Plant of Medical Preparations" is still Belarus. Providing the population of the country with high-quality, effective, affordable medicines is one of the strategic directions of the enterprise.
Modern equipment, the latest technologies, the most accurate methods of product quality control, qualified personnel - all these conditions determine the fact that tens of millions of people in many countries of the world rightfully trust the most valuable thing - their health - to the Open Joint-Stock Company "Borisov Plant of Medical Preparations".
Video presentation of the company:
Actual and legal address:
222518, Republic of Belarus,
Minsk region, Borisov,
64 Chapaev St.
The "hot line" is conducted by the organization's specialists on issues relevant to citizens and legal entities - once a quarter, on the 2nd Tuesday of the last month of the quarter from 8.00 to 8.30.
"Direct telephone line" conducted by the General Director, Chief Engineer, Deputy General Directors on issues relevant to citizens and legal entities - Once a quarter, 2nd Tuesday of the last month of the quarter from 8.00 to 8.30
| Job title | Full Name | Phone number |
| CEO | Fando Alexander Nikolaevich | 8 0177 73 22 61 |
| Chief Engineer | Deresh Vitaly Vasilievich | 8 0177 76 64 51 |
| Deputy General Director for Commercial Affairs | Lopatenko Vladimir Alekseevich | 8 0177 73 42 62 |
| Deputy General Director for Economics | Satsuk Larisa Adamovna | 8 0177 74 43 67 |
| Deputy General Director for Quality - Head of QCD | Baturo Tatyana Vasilievna | 8 0177 74 43 86 |
| Deputy General Director for Ideology, Human Resources and Social Affairs. | Kovaleva Natalya Leonidovna | 8 0177 73 78 07 |
Characteristics of JSC "Borisov Plant of Medical Preparations"
The object of study in the course work is the open joint-stock company "Borisov Plant of Medical Preparations" - a modern, dynamically developing enterprise in the pharmaceutical industry, which, in accordance with the needs of the population, the demands of healthcare and the pharmaceutical market, is increasing the range and volumes of manufactured drugs.
Name of the enterprise: Open Joint Stock Company "Borisov Plant of Medical Preparations.
Industry: Manufacture and sale of pharmaceutical and microbiological products.
Main activities and products: production and wholesale of medicines.
Legal address: Borisov, st. Chapaev, 64.
Form of ownership: republican.
Date of registration: 30.01.2009 decision of the Minsk Regional Executive Committee No. 5-r.
OJSC "Borisov Plant of Medical Preparations" was put into operation in 1965 as a pharmaceutical factory for the production of medicines for the needs of Belarus. In 1969, the factory was transferred to the category of enterprises of union subordination.
At present, JSC "Borisov Plant of Medical Preparations" is an enterprise of the Republic of Belarus, based on republican property, which is under the jurisdiction of the Belarusian State Concern for the production and sale of pharmaceutical and microbiological products.
The enterprise is an independent business entity with the rights of a legal entity, has an independent balance sheet, a settlement and currency account in the Borisov branch of BankBelVEB OJSC, a seal, a trademark, letterheads and stamps, samples of which are approved by its head. The enterprise operates on the principles of full cost accounting and can develop on mixed forms of ownership in accordance with applicable law.
The organizational structure of OJSC "Borisov Plant of Medical Preparations" has a linear functional form (Appendix A).
The management of the company is carried out in accordance with the current legislation and the Charter of the company on the basis of a combination of the rights and interests of the workforce and property owners.
The governing bodies are:
- - General Meeting of Shareholders;
- - supervisory board;
- - CEO.
The powers of the management bodies are determined by the Charter of the company.
The supreme governing body is the general meeting of shareholders, which is held at least once a year. Issues at the meeting are resolved according to the principle: one share - one vote.
A supervisory board is elected to carry out general management of the company's activities in the period between meetings of shareholders.
The executive body of the company is the General Director.
All subordinate managers are subordinate to the General Director. The General Director is the main organizer of the work and effective interaction of production units, sections, services. Combining economic and administrative methods of management, it ensures the organization's high-quality fulfillment of tasks, all obligations to the state budget, suppliers, customers, banks, and ensures compliance with the law in the activities of the enterprise.
A single vertical line of leadership and a direct path of active influence on subordinates have been created. Each line manager reports directly to the top management of the organization. However, employees perform different functions, which means that there is a division of divisions according to a functional basis, i.e. according to the specific tasks they have to solve. Through a rigid system of communications, the precise operation of each subsystem and the organization as a whole is ensured.
The advantage of such a control structure is simplicity, reliability and economy. The head in this case should cover all aspects of the enterprise. Functional divisions carry out all the technical preparation of the organization of work, prepare options for resolving issues related to the management of the preparation of the organization of work, relieve line managers from planning financial calculations, logistics and other issues.
Management functions are performed in accordance with the regulations on structural divisions, job descriptions, enterprise standards, instructions, management procedures and other documents.
Thus, the structure of the organization is based on a specialized division of labor, that is, work among people is not distributed randomly, but is assigned to specialists who are able to perform it best from the point of view of the organization as a whole.
The main advantages of the organizational structure of JSC "Borisov Plant of Medical Preparations" are:
- - quick implementation of actions on orders and instructions given by higher managers to lower ones,
- - a rational combination of linear and functional relationships;
- - stability of authority and responsibility for personnel.
- - unity and clarity of command;
- - prompt decision-making and implementation;
- - personal responsibility of each manager for the performance results;
- - professional problem solving by specialists of functional services.
However, the linear-functional management structure also has a number of disadvantages, such as:
- - duplication of the functions of the manager and functional specialists in the process of management activities;
- - slow decision making;
- - unwillingness of managers to take responsibility for decisions made;
- - the emergence of intra-production barriers that limit the scope of the interest of functional units in the effective development of production;
- - disagreements between line and functional services;
- - opposition of line managers to the work of functional specialists;
- - misinterpretation of information transmitted to line performers by functional managers.
Thus, the noted shortcomings do not lie in the plane of a specific linear organizational structure of management, but in the plane of the organization of the work of the enterprise, and can be eliminated by replacing some of the bureaucratic elements.
The company is constantly and purposefully working to improve the management system: programs are being developed and implemented to reform the system of organization and remuneration of labor, financial rehabilitation, technical re-equipment of the main production and marketing research in order to generate income from other activities.
Today, the range of manufactured products is about 200 types of drugs of 11 pharmacological groups.
The main activities of the enterprise are the production of:
- - injection solutions in ampoules and sterile powder forms of antibiotics;
- - tablet preparations;
- - liquid phytochemicals and soft dosage forms:
- - preparations in hard gelatin capsules;
- - original preparations based on oxidized cellulose, constituting the intellectual property of the enterprise.
The fundamental principle of the company's policy is to provide the population with affordable and high-quality medicines.
In accordance with this principle, the plant has chosen the production of import-substituting products (generics) as the main directions of its development, as well as expanding the range of original drugs that constitute the intellectual property of the enterprise, orientation and coordination of production and export policies in accordance with market requirements.
As part of the State Import Substitution Program, the plant annually masters the production of modern import-substituting drugs of various pharmacotherapeutic groups, which are in no way inferior in quality to imported analogues, but at a price lower than those.
The company owns more than 300 technologies for the production of medicines. There are about 200 types of medicines of 14 ATC-groups of the 1st level in the constant assortment of manufactured products. The leading ATC groups are J (28%) - antimicrobials for systemic use, N (28%) - drugs for the treatment of the nervous system, C (11%) - drugs for the treatment of the cardiovascular system. The structure of production for 2013 is shown in Figure 3.
Figure 3 - The structure of production in physical terms for 2013
Note - Source: own development
The volume of industrial output in actual prices for 2013 amounted to 917.3 billion rubles. (equivalent to $103.3 million).
Medicinal products manufactured by JSC "BZMP" are supplied on a regular basis not only to the neighboring Russian Federation and Ukraine, but also to Azerbaijan, Armenia, Afghanistan, Vietnam, Georgia, Egypt, Iraq, Yemen, Kazakhstan, North Korea, Kyrgyzstan, Latvia, Lebanon, Lithuania , Macedonia, Moldova, Uzbekistan, Somalia, USA, Tajikistan, Turkmenistan, Estonia. The plant plans to significantly expand the geography of sales in the very near future: to master the markets of South America, Africa, and Asian countries. This is facilitated by the active implementation of the GMP quality system at the enterprise.
For impressive export volumes, OJSC Borisov Plant of Medical Preparations has already been named the best exporter of the year three times: in 2008, 2010 and 2012. Every year the plant increases the volume of export products: in 2011. - by 7.4%, in 2012 - by 10.2%, by 5.6% in 2013 The volume of product exports in 2013 amounted to 55.4 million US dollars.
The volume and share of supplies in value terms are shown in Table 1.
Table 1 - Sales markets and their share in the total volume in 2012-2013
|
Delivery country |
|||||
|
The volume of deliveries, |
Volume of deliveries, thousand US dollars |
Share in total supplies, % |
|||
|
thousand US dollars |
|||||
|
Belarus |
|||||
|
Kazakhstan |
|||||
|
Uzbekistan |
|||||
|
Kyrgyzstan |
|||||
|
Turkmenistan |
|||||
|
Tajikistan |
|||||
|
Azerbaijan |
|||||
|
Other (return of raw materials) |
|||||
Related Articles
-
2022-05-28 07:46:52Solving some problems android version of mortal kombat x mobile -
2022-05-28 07:46:52How to make a parrot tame?
-
2022-05-16 11:43:03What is required to open a sole proprietorship?
Greetings, dear readers! Today we will talk about how to open an IP on your own in 2020 quickly and easily. In this article, I'll give you a step by step...
-
2022-05-16 11:43:03Evaluation of labor productivity of managers and HR specialists Basic rules of remuneration
Labor activity is an effort expediently aimed at achieving a certain result. This is the main feature of the work. He always...
-
2022-05-16 11:43:03Quality requirements
We can say that the basic requirements for the quality of products or services provided are a combination of its characteristics and properties, which in ...
-
2022-05-16 11:43:03Peat resources Milling peat extraction
Tolkacheva Elizaveta Sergeevna 9 "G" class MOU "Secondary School No. 58" Relevance of the topic Many foreign countries have a developed economy, thanks to a powerful ...
-
2022-05-07 03:07:16Closed Joint Stock Company Transtelecom
TTK is one of the five leading Russian telecom operators. The main shareholder of TTK is Russian Railways, which owns 99.99% of the Company's shares. Company...
How to disable ads on Android: remove pop-up ads
The Russian received a term and a million fine for "piracy Negative consequences of the law
Identification of key factors
The criteria for classifying organizations and individual entrepreneurs as small and medium-sized businesses have changed
See what "Royalty" is in other dictionaries Pitfalls of legislation